Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Fortress Biotech, Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing and commercializing pharmaceutical and biotechnology products.
IPO Date: December 1, 2011
Sector: Healthcare
Industry: Biotech
Market Cap: $57.37M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.08 | 3.64%
Avg Daily Range (30 D): $0.05 | 2.39%
Avg Daily Range (90 D): $0.05 | 2.71%
Institutional Daily Volume
Avg Daily Volume: .41M
Avg Daily Volume (30 D): .21M
Avg Daily Volume (90 D): .19M
Trade Size
Avg Trade Size (Sh.): 218
Avg Trade Size (Sh.) (30 D): 230
Avg Trade Size (Sh.) (90 D): 218
Institutional Trades
Total Inst.Trades: 36
Avg Inst. Trade: $2.41M
Avg Inst. Trade (30 D): $1.09M
Avg Inst. Trade (90 D): $1.09M
Avg Inst. Trade Volume: .03M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.49M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: 11.5K
   
News
May 30, 2025 @ 2:47 PM
Fortress Biotech Announces Closing of Sale of Subs...
Source: Globe Newswire
May 7, 2025 @ 12:00 PM
Fortress Biotech to Participate in the H.C. Wainwr...
Source: N/A
Feb 10, 2025 @ 1:00 PM
Mustang Bio Announces Closing of $8 Million Public...
Source: N/A
Feb 6, 2025 @ 12:00 PM
Mustang Bio Announces Pricing of $8 Million Public...
Source: Globe Newswire
Feb 6, 2025 @ 12:00 PM
Mustang Bio Announces Pricing of $8 Million Public...
Source: N/A
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-.48 $-.26 $-2.69
Diluted EPS $-.48 $-.26 $-2.69
Revenue $ 13.14M $ 15.12M $ 57.68M
Gross Profit $ 8.35M $ 12.88M $ 36.8M
Net Income / Loss $ -24.69M $ -26.32M $ -120.86M
Operating Income / Loss $ -22.32M $ -23.84M $ -110.38M
Cost of Revenue $ 4.79M $ 2.24M $ 20.88M
Net Cash Flow $ 33.74M $ -24.55M $ -24.55M
PE Ratio    
Splits
Oct 10, 2023:   1:15
Dec 06, 2022:   1:10